Hyalomma marginatum is a hard tick species of medical and veterinary importance that is widely distributed throughout Turkey. In this study, five novel polymorphic microsatellite markers were isolated and developed from partial genome information using the Hiseq Illumina paired end technology. A total of 20,943,321 reads were obtained from vegetation collected specimens, 103 primer pairs were randomly selected for the analysis and 62 of them were tested for polymorphism. Seventy five specimens from nine different localities of Turkey were genotyped. Markers for selected loci were tested using labeled primers on capillary electrophoresis. Five loci were successfully scored and used to analyze genetic diversity. The number of alleles per locus ranged from 4 to 7, with an average of 5.4 alleles per locus. The average observed and expected heterozygosity values were 0.314 and 0.468, respectively. Two loci deviated significantly from Hardy-Weinberg expectations. No significant linkage disequilibrium was detected between loci. This study is the first attempt to generate genome sequence data and to develop SSR markers for H. marginatum. These markers will be useful to understand the taxonomic status of this vector, its population dynamics, and spatial distributions as well as mechanisms underlying Crimean Congo Heamorrhagic Fever transmission and the development and implementation of well-designed prevention strategies.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.